Ozempic Lawsuit – July 2026 Update
US$ 28.54
glp-1 and levothyroxine Glucagon-like peptide 1 receptor agonist use risk of thyroid cancer: Scandinavian cohort study Study Assuages Thyroid Cancer Fears
Description
Currently, multiple GLP-1R agonists are indicated for the treatment of T2D, and liraglutide is also approved for obesity
Diabetes Obes Metab 2024;26:363341.ArticlePubMed 78
Just intentional
Several limitations should be considered
But as these medications become more widely prescribed, patients are reporting an unexpected side effect: hair loss
